CAS 1070773-09-9

RK-33

CAS : 1070773-09-9

Formule : C₂₃H₂₀N₆O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 428.4433

Ref: IN-DA01ENVM

RK 33

CAS : 1070773-09-9

Formule : C₂₃H₂₀N₆O₃

Masse moléculaire : 428.45

Ref: 4Z-R-161001

RK33

CAS : 1070773-09-9

RK33

Degré de pureté : ≥95%

Masse moléculaire : 428.44g/mol

Ref: 54-BUP05962

RK 33-d6

CAS : 1070773-09-9

Formule : C₂₃H₁₄D₆N₆O₃

Masse moléculaire : 434.49

Ref: 4Z-R-161002

RK33

CAS : 1070773-09-9

"RK33 is a DDX3 inhibitor causing G1 arrest, apoptosis, and radiation sensitization in DDX3-overexpressing cells."

Formule : C₂₃H₂₀N₆O₃

Degré de pureté : 99.04% - 99.72%

Couleur et forme : Solid

Masse moléculaire : 428.44

Ref: TM-T6970

RK 33

Produit contrôlé

CAS : 1070773-09-9

Applications RK 33 is an inhibitor of DDX3, an ATP-dependent RNA helicase (1). Aberrant regulation of DDX3 is related to various diseases such as prostate and breast cancer (2). RK 33 was shown to decrease proliferation of prostate cancer cells and induced a G1 phase cell-cycle arrest (2).
References (1) Botlagunta, M. et al.: PLoS One. 6, e17563 (2011) (2) Xie, M., et al.: Cancer Res. 76, 6340 (2016)

Formule : C₂₃H₂₀N₆O₃

Couleur et forme : Neat

Masse moléculaire : 428.44

Ref: TR-R545500

RK-33

CAS : 1070773-09-9

RK-33 is a small molecule inhibitor, which is synthesized as a chemical compound. It functions by targeting and inhibiting the activity of DDX3, a DEAD-box RNA helicase, which plays a crucial role in the modulation of RNA biogenesis and translation processes. By interfering with DDX3, RK-33 disrupts processes essential for the proliferation of certain cancer cells, making it a significant focus in cancer research.

Formule : C₂₃H₂₀N₆O₃

Degré de pureté : Min. 95%

Masse moléculaire : 428.44 g/mol

Ref: 3D-VSB77309